For investors
The thesis.
HabitCure is a biosignal inference engine wrapped in four editions of a consumer app. The moat is the engine. The wedge is the app. The market is everyone with a heartbeat.
Where we are
- Closed TestFlight beta, live today
- Five USPTO provisional patents filed May 2026, inventor Eric Jay Duchin
- Four editions in build: Consumer, Elite, Professional, Military
- Unified engine — one inference brain, four surfaces
- iOS-first, launching publicly late 2026
The wedge
Every wearable on the market shows you what happened. HabitCure shows you what's drifting — days before the event. Cardiac Drift, glucose morphology, paired-window athletic, pathway conflict. Real detection, not report cards.
The moat
The engine is patent-pending. The engine runs across four editions of a single app. Every edition compounds the training signal for every other edition. Consumer usage feeds Elite thresholds. Elite thresholds feed Professional pilots. Professional pilots feed Military deployment. Same brain, four surfaces.
The market
- Consumer: 500M+ Apple Watch owners plus growing CGM population (Stelo, Lingo launching)
- Elite: 200K+ paid coaching relationships in the US alone
- Professional: 1M+ US clinicians who could deploy a paired-window tool
- Military: 1.3M active-duty US service members, plus allied forces
Materials
Investor deck
Full pitch deck. Vision, product, patents, team, market, ask. Email for access.
Diligence pack
Cap table, financials, patent filings, tech stack, security posture. Under NDA.
TestFlight walkthrough
30-minute live demo of the current build. Book directly with Rick.
Contact
Rick handles investor conversations personally: investors@habitcure.com
Please include: name, firm, check size, and one sentence on why HabitCure. Rick replies within 24 hours.